drugset / Trial / NCT05411146
A Study Investigating the Safety, Absorption, and Elimination of Radioactively Labeled Etrumadenant, a New Compound in the Treatment of Cancer
NaSingle-groupOpen-labelBasic science
Summary
This study will assess absorption, metabolism, and excretion of Radioactively Labeled Etrumadenant in healthy volunteers.
Timeline
- Start
- 2022-05-25
- Primary completion
- 2022-07-07
- Completion
- 2022-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etrumadenant | Small molecule | — | Oral |
Indications
No indication recorded.